Lv1
48 积分 2025-07-10 加入
Brain-shuttle biologics chart new paths across the blood–brain barrier
3天前
已完结
Antitumor Cytotoxic Activity Retained in Tolerized T Cells Following Daily Dose Escalation of a T‐Cell Engager in Cynomolgus Monkeys to Mitigate Cytokine Release Syndrome
16天前
已完结
An FDA analysis of clinical hold deficiencies affecting investigational new drug applications for oncology products
19天前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
19天前
已完结
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
21天前
已完结
Impurities in Oligonucleotide Drug Substances and Drug Products
1个月前
已完结
Current CMC challenges in oligonucleotide API development: from IND to NDA
1个月前
已完结
Bispecific antibody–drug conjugates: a modular blueprint for next-generation cancer therapeutics
1个月前
已完结
Re-evaluating antibody–drug conjugate linker stability: assessment, interpretation, and clinical translation
1个月前
已完结
The next generation of antibody–drug conjugates
1个月前
已完结
皖公网安备34019202002308
